Voruciclib Hydrochloride

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameVoruciclib Hydrochloride
Drug Alias Name伏罗西利盐酸盐Voruciclibumvoruciclib盐酸沃卢西利盐酸伏罗西利 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 2 inhibitors +[5] 
TargetsCyclin-dependent kinase 1Cyclin-dependent kinase 4Cyclin-dependent kinase 9 +[5] 
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsMelanoma +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesIndia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPiramal Phytocare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPiramal Enterprises LtdPresage Biosciences IncMei Pharma Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic NeoplasmsMelanoma +[10] 

Other Information

ATC CodeN/A
Related LinksN/A